A clinical Study on the Efficacy of Fluticasone Vs Bharangi Arka Nasal Spray in Pratishyaya (Chronic Allergic Rhinitis) in Children.

Recruiting

Conditions: Chronic rhinitis. Ayurveda Condition: PRATISYAYAH/PINASAH,

Registration Number: CTRI/2022/06/043408

Lead Sponsor: DrDeepthi Balakrishnan

Brief Summary: Autism spectrum disorder (ASD) is a complex developmental condition characterized by qualitative abnormalities in social interactions, reduced communication skills, and restricted repetitive behaviors and activities. There is no direct reference to ASD in *Samhitas* and it can be considered as an *Anukta* *vyadhi*. *Unmada*, a disease that afflicts *manovaha* *srothas,*is characterized by the perversion of intellect, mind, and memory.ASD can be correlated to *Vatika* *unmada*. The treatment of *unmada* involves various *Ayurvedic* formulations. *Medha* *gulika* is a polyherbal formulation indicated in anxiety and mental depression, dementia and it improves memory, concentration, and brain functioning (*medhya*). *Bhunaga* *Talia* is an *anubhootayoga* indicated in treatment of *apasmara*, *bhootonmada*, *vaksanga* etc.*Nasya* and *shiroshirodhara* are effective in treating *manovaha* *srothovikaras***.***Bhunaga* *taila* and *Medha* *gulika* can be combined to develop an effective treatment protocol for ASD. The main aim of this study is to develop a protocol of treatment for a patient suffering from ASD, which helps manage the symptoms and make behavioral improvement. A 5-year-old female child who was brought to the OPD with the diagnosis of ASD was treated with both these medicines and the changes before and after the treatment was noted based on the Trivandrum Autism Behavioral Checklist (TABC). Minimal improvement was noted in the behavior of the child following treatment of 90 days.

Detailed Description: Not available

Recruitment & Eligibility

Status: Open to Recruitment

Sex: All

Target Recruitment: 84

Inclusion Criteria

1 Patients irrespective of gender, religion, and socioeconomic status.
2 Patients with Pratishyaya for more than 1 week or recurrent 3-6 episodes in a year (Chronic Allergic Rhinitis).
3 Parents who are ready to provide written informed consent to their children.

Exclusion Criteria

1 Patients with Acute Allergic Rhinitis.
2 DushtaPratishyaya, RakthaPratishyaya and SannipatajaPratishyaya.
3 Infectious diseases like T.B. 4 Patients suffering from Cleft Palate, DNS, and Nasal Polyps.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Rhinorrhea and Sneezing expected to decrease after treatment from 1st day to the 7th day	1st day \| 7th day

Secondary Outcome Measures

Name	Time	Method
Kasam,Shirashoola,Aruchi,Nasal Itching and Nasal Obstruction expected to decrease after treatment from 8th to 28th	8th day

Trial Locations

Locations (1): MAHATMA GANDHI AYURVED COLLEGE, HOSPITAL & RESEARCH CENTRE
🇮🇳
Wardha, MAHARASHTRA, India
MAHATMA GANDHI AYURVED COLLEGE, HOSPITAL & RESEARCH CENTRE
🇮🇳Wardha, MAHARASHTRA, India
Dr Renu Rathi
Principal investigator
9373703816
rbr.226@gmail.com